Adenosine A2A-dopamine D2 receptor-receptor heteromers. Targets for neuro-psychiatric disorders

Parkinsonism and Related Disorders

Volumn 10, Issue 5, 2004, Pages 265-271

  Ferré, Sergi ^a   Ciruela, Francisco ^b   Canals, Meritxell ^b   Marcellino, Daniel ^b   Burgueno, Javier ^b   Casadó, Vicent ^b   Hillion, Joëlle ^c   Torvinen, Maria ^d   Fanelli, Francesca ^e   De Benedetti, Piero ^e   Goldberg, Steven R ^a   Bouvier, Michel ^f   Fuxe, Kjell ^d   Agnati, Luigi F ^e   Lluis, Carme ^b   Franco, Rafael ^b   Woods, Amina ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF BARCELONA   (Spain)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^f UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Adenosine A2A receptor; Dopamine D2 receptor; Drug addiction; Epitope epitope interaction; Heteromers; Parkinson's disease; Schizophrenia

Indexed keywords

ADENOSINE A2 RECEPTOR; DOPAMINE 2 RECEPTOR; ADENOSINE A2A RECEPTOR;

CONFERENCE PAPER; DENDRITIC CELL; HUMAN; MOLECULAR DYNAMICS; NEUROPSYCHIATRY; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SCHIZOPHRENIA; ANIMAL; CHEMISTRY; CORPUS STRIATUM; DRUG DELIVERY SYSTEM; DRUG EFFECT; GLOBUS PALLIDUS; MENTAL DISEASE; METABOLISM; METHODOLOGY; NERVE CELL; REVIEW;

ANIMALS; CORPUS STRIATUM; DRUG DELIVERY SYSTEMS; GLOBUS PALLIDUS; HUMANS; MENTAL DISORDERS; NEURONS; RECEPTOR, ADENOSINE A2A; RECEPTORS, DOPAMINE D2;

EID: 2942552330     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2004.02.014     Document Type: Conference Paper

References (49)

1. Agnati L.F., Ferré S., Lluis C., Franco R., Fuxe K. Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol Rev. 55:2003;509-550
2. Agnati L.F., Franzen O., Ferré S., Leo G., Franco R., Fuxe K. Possible role of intramembrane receptor-receptor interactions in memory and learning via formation of long-lived heteromeric complexes: focus on motor learning in the basal ganglia. J Neural Transm Suppl. 65:2003;1-28
3. 2 receptor interactions in the striatum. Implications for drug therapy in neuro-psychiatric disorders and drug abuse. Curr Med Chem - Central Nervous System Agents. 3:2003;1-26
4. Zoli M., Agnati L.F., Hedlund P.B., Li X.M., Ferre S., Fuxe K. Receptor-receptor interactions as an integrative mechanism in nerve cells. Mol Neurobiol. 7:1993;293-334
5. Bouvier M. Oligomerization of G-protein-coupled transmitter receptors. Nat Rev Neurosci. 2:2001;274-286
6. Ferré S. Adenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia. Psychopharmacology. 133:1997;107-120
7. Heimer L., Zahm D.S., Alheid G.F. Basal ganglia. Paxinos G. The rat nervous system. 1995;579-628 Academic Press, San Diego
8. Gerfen C.R., Wilson C.J. The basal ganglia. Swanson L.W., Björklund A., Hökfelt T. Handbook of chemical neuroanatomy. vol. 12:1996;317-468 Elsevier, Amsterdam
9. Obeso J.A., Rodriguez-Oroz M.C., Rodriguez M., Lanciego J.L., Artieda J., Gonzalo N., Olanow C.W. Pathophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci. 23:2000;S8-S19
10. Koob G.F. The role of the striatopallidal and extended amygdala systems in drug addiction. Ann NY Acad Sci. 877:1999;445-460
11. Ferré S., Fuxe K., von Euler G., Johansson B., Fredholm B.B. Adenosine-dopamine interactions in the brain. Neuroscience. 51:1992;501-512
12. Ferré S., Fredholm B.B., Morelli M., Popoli P., Fuxe K., Ferre S., Fredholm B.B., Morelli M., Popoli P., Fuxe K. Trends Neurosci. 20:1997;482-487
13. Schiffmann S.N., Jacobs O., Vanderhaeghen J.J. Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. J Neurochem. 57:1991;1062-1067
14. Hettinger B.D., Lee A., Linden J., Rosin D.L. Ultrastructural localization of adenosine A2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum. J Comp Neurol. 431:2001;331-346
15. Yung K.K., Bolam J.P., Smith A.D., Hersch S.M., Ciliax B.J., Levey A.I. Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience. 65:1995;709-730
16. Delle Donne K.T., Sesack S.R., Pickel V.M. Ultrastructural immunocytochemical localization of the dopamine D2 receptor within GABAergic neurons of the rat striatum. Brain Res. 746:1997;239-255
17. Meredith G.E., De Souza I.E., Hyde T.M., Tipper G., Wong M.L., Egan M.F. Persistent alterations in dendrites, spines, and dynorphinergic synapses in the nucleus accumbens shell of rats with neuroleptic-induced dyskinesias. J Neurosci. 20:2000;7798-7806
18. Gerdeman G.L., Partridge J.G., Lupica C.R., Lovinger D.M. It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci. 26:2003;184-192
19. Li Y., Kolb B., Robinson T.E. The location of persistent amphetamine-induced changes in the density of dendritic spines on medium spiny neurons in the nucleus accumbens and caudate-putamen. Neuropsychopharmacology. 28:2003;1082-1085
20. Ferré S., Rubio A., Fuxe K. Stimulation of adenosine A2 receptors induces catalepsy. Neurosci Lett. 130:1991;162-164
21. Bara-Jimenez W., Sherzai A., Dimitrova T., Favit A., Bibbiani F., Gillespie M., Morris M.J., Mouradian M.M., Chase T.N. Adenosine A(2A) receptor antagonist treatment of Parkinson's disease. Neurology. 61:2003;293-296
22. Hauser R.A., Hubble J.P., Truong D.D. Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD. Neurology. 61:2003;297-303
23. Akhondzadeh S., Shasavand E., Jamilian H., Shabestari O., Kamalipour A. Dipyridamole in the treatment of schizophrenia: adenosine-dopamine receptor interactions. J Clin Pharm Ther. 25:2000;131-137
24. Ferré S., von Euler G., Johansson B., Fredholm B.B., Fuxe K. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc Natl Acad Sci USA. 88:1991;7238-7241
25. Díaz-Cabiale Z., Hurd Y., Guidolin D., Finnman U.B., Zoli M., Agnati L.F., Vanderhaeghen J.J., Fuxe K., Ferré S. Adenosine A2A agonist CGS 21680 decreases the affinity of dopamine D2 receptors for dopamine in human striatum. Neuroreport. 12:2001;1831-1834
26. Dasgupta S., Ferré S., Kull B., Hedlund P.B., Finnman U.B., Ahlberg S., Arenas E., Fredholm B.B., Fuxe K. Adenosine A2A receptors modulate the binding characteristics of dopamine D2 receptors in stably cotransfected fibroblast cells. Eur J Pharmacol. 316:1996;325-331
27. Kull B., Ferré S., Arslan G., Svenningsson P., Fuxe K., Owman C., Fredholm B.B. Reciprocal interactions between adenosine A2A and dopamine D2 receptors in Chinese hamster ovary cells co-transfected with the two receptors. Biochem Pharmacol. 58:1999;1035-1045
28. Salim H., Ferré S., Dalal A., Peterfreund R.A., Fuxe K., Vincent J.D., Lledo P.M. Activation of adenosine A1 and A2A receptors modulates dopamine D2 receptor-induced responses in stably transfected human neuroblastoma cells. J Neurochem. 74:2000;432-439
29. Hillion J., Canals M., Torvinen M., Casado V., Scott R., Terasmaa A., Hansson A., Watson S., Olah M.E., Mallol J., Canela E.I., Zoli M., Agnati L.F., Ibanez C.F., Lluis C., Franco R., Ferré S., Fuxe K. Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors. J Biol Chem. 277:2002;18091-18097
30. Kudlacek O., Just H., Korkhov V.M., Vartian N., Klinger M., Pankevych H., Yang Q., Nanoff C., Freissmuth M., Boehm S. The human D2 dopamine receptor synergizes with the A2A adenosine receptor to stimulate adenylyl cyclase in PC12 cells. Neuropsychopharmacology. 28:2003;1317-1327
31. Vortherms T.A., Watts V.J. Sensitization of neuronal A2A adenosine receptors following persistent D2 dopamine receptor activation. J Pharmacol Exp Ther. 308:2004;221-227
32. Yao L., Arolfo M.P., Dohrman D.P., Jiang Z., Fan P., Fuchs S., Janak P.H., Gordon A.S., Diamond I. Betagamma Dimers mediate synergy of dopamine D2 and adenosine A2 receptor-stimulated PKA signaling and regulate ethanol consumption. Cell. 109:2002;733-743
33. Lee K.W., Hong J.H., Choi I.Y., Che Y., Lee J.K., Yang S.D., Song C.W., Kang H.S., Lee J.H., Noh J.S., Shin H.S., Han P.L. Impaired D2 dopamine receptor function in mice lacking type 5 adenylyl cyclase. J Neurosci. 22:2002;7931-7940
34. Thomas J.M., Hoffman B.B. Isoform-specific sensitization of adenylyl cyclase activity by prior activation of inhibitory receptors: role of beta gamma subunits in transducing enhanced activity of the type VI isoform. Mol Pharmacol. 49:1996;907-914
35. Watts V.J. Molecular mechanisms for heterologous sensitization of adenylate cyclase. J Pharmacol Exp Ther. 302:2002;1-7
36. Hernandez-Lopez S., Tkatch T., Perez-Garci E., Galarraga E., Bargas J., Hamm H., Surmeier D.J. D2 dopamine receptors in striatal medium spiny neurons reduce L-type Ca2+currents and excitability via a novel PLC[beta]1-IP3- calcineurin-signaling cascade. J Neurosci. 20:2000;8987-8995
37. Dolmetsch R.E., Pajvani U., Fife K., Spotts J.M., Greenberg M.E. Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway. Science. 294:2001;333-339
38. Canals M., Marcellino D., Fanelli F., Ciruela F., De Benedetti P., Goldberg S.R., Fuxe K., Agnati L.F., Woods A.S., Ferré S., Lluis C., Bouvier M., Franco R. Adenosine A2A-dopamine D2 receptor-receptor heteromerization. Qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J Biol Chem. 47:2003;46741-46749
39. Ciruela F, Burgueño J, Casadó V, Canals M, Marcellino D, Goldberg SR, Bader M, Fuxe K, Agnatil LF, Lluis C, Franco F, Ferré S. Woods AS. Adenosine A2A-dopamine D2 receptor-receptor heteromerization. Involvement of epitope-epitope electrostatic interactions (submitted for publication).
40. Woods A.S., Huestis M.A. A study of peptide-peptide interaction by matrix-assisted laser desorption/ionization. J Am Soc Mass Spectrom. 12:2001;88-96
41. Woods A.S., Koomen J.M., Ruotolo B.T., Gillig K.J., Russel D.H., Fuhrer K., Gonin M., Egan T.F., Schultz J.A. A study of peptide-peptide interactions using MALDI ion mobility o-TOF and ESI mass spectrometry. J Am Soc Mass Spectrom. 13:2002;166-169
42. Woods A.S., Moyer S.C., Wang H.Y., Wise R.A. Interaction of chlorisondamine with the neuronal nicotinic acetylcholine receptor. J Proteome Res. 2:2003;207-212
43. Liu F., Virshup D.M., Nairn A.C., Greengard P. Mechanism of regulation of casein kinase I activity by group I metabotropic glutamate receptors. J Biol Chem. 277:2002;45393-45399
44. Ferré S., Karcz-Kubicha M., Hope B.T., Popoli P., Burgueno J., Gutierrez M.A., Casado V., Fuxe K., Goldberg S.R., Lluis C., Franco R., Ciruela F. Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function. Proc Natl Acad Sci USA. 99:2002;11940-11945
45. Nishi A., Liu F., Matsuyama S., Hamada M., Higashi H., Nairn A.C., Greengard P. Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling. Proc Natl Acad Sci USA. 100:2003;1322-1327
46. Ferré S., Popoli P., Rimondini R., Reggio R., Kehr J., Fuxe K. Adenosine A2A and group I metabotropic glutamate receptors synergistically modulate the binding characteristics of dopamine D2 receptors in the rat striatum. Neuropharmacology. 38:1999;129-140
47. Popoli P., Pezzola A., Torvinen M., Reggio R., Pintor A., Scarchilli L., Fuxe K., Ferré S. The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors. Neuropsychopharmacology. 25:2001;505-513
48. Lin R., Karpa K., Kabbani N., Goldman-Rakic P., Levenson R. Dopamine D2 and D3 receptors are linked to the actin cytoskeleton via interaction with filamin A. Proc Natl Acad Sci USA. 98:2001;5258-5263
49. Binda A.V., Kabbani N., Lin R., Levenson R. D2 and D3 dopamine receptor cell surface localization mediated by interaction with protein 4.1N. Mol Pharmacol. 62:2002;507-513